Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 656 entries
Sorted by: Best Match Show Resources per page
Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry.

Food research international (Ottawa, Ont.)

Sommella E, Pepe G, Pagano F, Ostacolo C, Tenore GC, Russo MT, Novellino E, Manfra M, Campiglia P.
PMID: 28455027
Food Res Int. 2015 Oct;76:466-477. doi: 10.1016/j.foodres.2015.05.044. Epub 2015 May 29.

Annurca apple, a Southern Italian cultivar, possesses not only a particular taste and flavor, different from other types of apple, but also several healthy properties. With the aim to thoroughly elucidate the polyphenolic profile of this variety, listed as...

Cite
Sommella E, Pepe G, Pagano F, et al. Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food Res Int. 2015;76:466-477doi: 10.1016/j.foodres.2015.05.044.
Sommella, E., Pepe, G., Pagano, F., Ostacolo, C., Tenore, G. C., Russo, M. T., Novellino, E., Manfra, M., & Campiglia, P. (2015). Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food research international (Ottawa, Ont.), 76466-477. https://doi.org/10.1016/j.foodres.2015.05.044
Sommella, Eduardo, et al. "Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry." Food research international (Ottawa, Ont.) vol. 76 (2015): 466-477. doi: https://doi.org/10.1016/j.foodres.2015.05.044
Sommella E, Pepe G, Pagano F, Ostacolo C, Tenore GC, Russo MT, Novellino E, Manfra M, Campiglia P. Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food Res Int. 2015 Oct;76:466-477. doi: 10.1016/j.foodres.2015.05.044. Epub 2015 May 29. PMID: 28455027.
Copy Download .nbib Format: NLM
Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling.

eLife

Calcagnì A, Kors L, Verschuren E, De Cegli R, Zampelli N, Nusco E, Confalonieri S, Bertalot G, Pece S, Settembre C, Malouf GG, Leemans JC, de Heer E, Salvatore M, Peters DJ, Di Fiore PP, Ballabio A.
PMID: 27668431
Elife. 2016 Sep 26;5. doi: 10.7554/eLife.17047.

No abstract available.

Cite
Calcagnì A, Kors L, Verschuren E, et al. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife. 2016;5doi: 10.7554/eLife.17047.
Calcagnì, A., Kors, L., Verschuren, E., De Cegli, R., Zampelli, N., Nusco, E., Confalonieri, S., Bertalot, G., Pece, S., Settembre, C., Malouf, G. G., Leemans, J. C., de Heer, E., Salvatore, M., Peters, D. J., Di Fiore, P. P., & Ballabio, A. (2016). Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. eLife, 5. https://doi.org/10.7554/eLife.17047
Calcagnì, Alessia, et al. "Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling." eLife vol. 5 (2016). doi: https://doi.org/10.7554/eLife.17047
Calcagnì A, Kors L, Verschuren E, De Cegli R, Zampelli N, Nusco E, Confalonieri S, Bertalot G, Pece S, Settembre C, Malouf GG, Leemans JC, de Heer E, Salvatore M, Peters DJ, Di Fiore PP, Ballabio A. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife. 2016 Sep 26;5. doi: 10.7554/eLife.17047. PMID: 27668431; PMCID: PMC5036965.
Copy Download .nbib Format: NLM
Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli.

Frontiers in microbiology

Baranzoni GM, Fratamico PM, Gangiredla J, Patel I, Bagi LK, Delannoy S, Fach P, Boccia F, Anastasio A, Pepe T.
PMID: 27148249
Front Microbiol. 2016 Apr 21;7:574. doi: 10.3389/fmicb.2016.00574. eCollection 2016.

Similar to ruminants, swine have been shown to be a reservoir for Shiga toxin-producing Escherichia coli (STEC), and pork products have been linked with outbreaks associated with STEC O157 and O111:H-. STEC strains, isolated in a previous study from...

Cite
Baranzoni GM, Fratamico PM, Gangiredla J, et al. Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Front Microbiol. 2016;7:574doi: 10.3389/fmicb.2016.00574.
Baranzoni, G. M., Fratamico, P. M., Gangiredla, J., Patel, I., Bagi, L. K., Delannoy, S., Fach, P., Boccia, F., Anastasio, A., & Pepe, T. (2016). Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Frontiers in microbiology, 7574. https://doi.org/10.3389/fmicb.2016.00574
Baranzoni, Gian Marco, et al. "Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli." Frontiers in microbiology vol. 7 (2016): 574. doi: https://doi.org/10.3389/fmicb.2016.00574
Baranzoni GM, Fratamico PM, Gangiredla J, Patel I, Bagi LK, Delannoy S, Fach P, Boccia F, Anastasio A, Pepe T. Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Front Microbiol. 2016 Apr 21;7:574. doi: 10.3389/fmicb.2016.00574. eCollection 2016. PMID: 27148249; PMCID: PMC4838603.
Copy Download .nbib Format: NLM
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes.

Journal of clinical laboratory analysis

Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A.
PMID: 29484706
J Clin Lab Anal. 2018 Jul;32(6):e22418. doi: 10.1002/jcla.22418. Epub 2018 Feb 27.

BACKGROUND: Breast cancer (BC) is the most common neoplasm in women, with 5%-10% patients showing a familial predisposition, where germline mutations in BRCA1/BRCA2 genes are found in -20% of cases. Next-generation sequencing (NGS) is among the best available options...

Cite
Guacci A, Cordella A, Rocco T, et al. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal. 2018;32(6):e22418doi: 10.1002/jcla.22418.
Guacci, A., Cordella, A., Rocco, T., Giurato, G., Nassa, G., Rizzo, F., Carlomagno, C., Pepe, S., Tarallo, R., & Weisz, A. (2018). Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. Journal of clinical laboratory analysis, 32(6), e22418. https://doi.org/10.1002/jcla.22418
Guacci, Anna, et al. "Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes." Journal of clinical laboratory analysis vol. 32,6 (2018): e22418. doi: https://doi.org/10.1002/jcla.22418
Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal. 2018 Jul;32(6):e22418. doi: 10.1002/jcla.22418. Epub 2018 Feb 27. PMID: 29484706; PMCID: PMC6817177.
Copy Download .nbib Format: NLM
Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials.

Experimental and therapeutic medicine

Carlomagno C, Daniele G, Bianco R, Marciano R, Damiano V, Matano E, Nappi L, Pepe S, DE Placido S, Tortora G.
PMID: 22977524
Exp Ther Med. 2011 May;2(3):449-455. doi: 10.3892/etm.2011.218. Epub 2011 Feb 25.

The combination of EGFR inhibitors and anti-angiogenic drugs has a strong pre-clinical rationale, yet its use has produced controversial clinical results. We conducted two sequential phase I trials to evaluate the feasibility and the recommended dose of erlotinib when...

Cite
Carlomagno C, Daniele G, Bianco R, et al. Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Exp Ther Med. 2011;2(3):449-455doi: 10.3892/etm.2011.218.
Carlomagno, C., Daniele, G., Bianco, R., Marciano, R., Damiano, V., Matano, E., Nappi, L., Pepe, S., DE Placido, S., & Tortora, G. (2011). Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Experimental and therapeutic medicine, 2(3), 449-455. https://doi.org/10.3892/etm.2011.218
Carlomagno, Chiara, et al. "Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials." Experimental and therapeutic medicine vol. 2,3 (2011): 449-455. doi: https://doi.org/10.3892/etm.2011.218
Carlomagno C, Daniele G, Bianco R, Marciano R, Damiano V, Matano E, Nappi L, Pepe S, DE Placido S, Tortora G. Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Exp Ther Med. 2011 May;2(3):449-455. doi: 10.3892/etm.2011.218. Epub 2011 Feb 25. PMID: 22977524; PMCID: PMC3440709.
Copy Download .nbib Format: NLM
Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Pepe C, Teich V, Coutinho MB, Almeida S.
PMID: 27201674
Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1677. Epub 2014 Oct 26.

No abstract available.

Cite
Pepe C, Teich V, Coutinho MB, et al. Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value Health. 2014;17(7):A529doi: 10.1016/j.jval.2014.08.1677.
Pepe, C., Teich, V., Coutinho, M. B., & Almeida, S. (2014). Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A529. https://doi.org/10.1016/j.jval.2014.08.1677
Pepe, C, et al. "Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A529. doi: https://doi.org/10.1016/j.jval.2014.08.1677
Pepe C, Teich V, Coutinho MB, Almeida S. Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1677. Epub 2014 Oct 26. PMID: 27201674.
Copy Download .nbib Format: NLM
The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia.

SpringerPlus

Bergamini C, Perniola R, Cardone MF, Gasparro M, Pepe R, Caputo AR, Antonacci D.
PMID: 27652135
Springerplus. 2016 Sep 14;5(1):1562. doi: 10.1186/s40064-016-3228-8. eCollection 2016.

Vitis vinifera L. varieties were spread through cuttings following historic migrations of people, trades, or after biological crises due to pests outbreaks. Some today's varieties could be more than a 1000 years old and, although over the centuries these...

Cite
Bergamini C, Perniola R, Cardone MF, et al. The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. Springerplus. 2016;5(1):1562doi: 10.1186/s40064-016-3228-8.
Bergamini, C., Perniola, R., Cardone, M. F., Gasparro, M., Pepe, R., Caputo, A. R., & Antonacci, D. (2016). The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. SpringerPlus, 5(1), 1562. https://doi.org/10.1186/s40064-016-3228-8
Bergamini, C, et al. "The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia." SpringerPlus vol. 5,1 (2016): 1562. doi: https://doi.org/10.1186/s40064-016-3228-8
Bergamini C, Perniola R, Cardone MF, Gasparro M, Pepe R, Caputo AR, Antonacci D. The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. Springerplus. 2016 Sep 14;5(1):1562. doi: 10.1186/s40064-016-3228-8. eCollection 2016. PMID: 27652135; PMCID: PMC5023643.
Copy Download .nbib Format: NLM
Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid.

Journal of herbal medicine

Fuentes AL, Hennessy K, Pascual J, Pepe N, Wang I, Santiago A, Chaggan C, Martinez J, Rivera E, Cota P, Cunha C, Nogaj LA, Moffet DA.
PMID: 27042401
J Herb Med. 2016 Mar;6(1):37-41. doi: 10.1016/j.hermed.2015.11.001.

The extracts of 27 vegetables, spices and herbs were screened for their functional ability to inhibit the aggregation of islet amyloid polypeptide (IAPP, amylin) into toxic amyloid aggregates. The aggregation of IAPP has been directly linked to the death...

Cite
Fuentes AL, Hennessy K, Pascual J, et al. Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. J Herb Med. 2016;6(1):37-41doi: 10.1016/j.hermed.2015.11.001.
Fuentes, A. L., Hennessy, K., Pascual, J., Pepe, N., Wang, I., Santiago, A., Chaggan, C., Martinez, J., Rivera, E., Cota, P., Cunha, C., Nogaj, L. A., & Moffet, D. A. (2016). Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. Journal of herbal medicine, 6(1), 37-41. https://doi.org/10.1016/j.hermed.2015.11.001
Fuentes, Ana Lucia, et al. "Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid." Journal of herbal medicine vol. 6,1 (2016): 37-41. doi: https://doi.org/10.1016/j.hermed.2015.11.001
Fuentes AL, Hennessy K, Pascual J, Pepe N, Wang I, Santiago A, Chaggan C, Martinez J, Rivera E, Cota P, Cunha C, Nogaj LA, Moffet DA. Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. J Herb Med. 2016 Mar;6(1):37-41. doi: 10.1016/j.hermed.2015.11.001. PMID: 27042401; PMCID: PMC4815265.
Copy Download .nbib Format: NLM
On the photovoltaic effect in local field potential recordings.

Neurophotonics

Mikulovic S, Pupe S, Peixoto HM, Do Nascimento GC, Kullander K, Tort AB, Leão RN.
PMID: 26835485
Neurophotonics. 2016 Jan;3(1):015002. doi: 10.1117/1.NPh.3.1.015002. Epub 2016 Jan 19.

Optogenetics allows light activation of genetically defined cell populations and the study of their link to specific brain functions. While it is a powerful method that has revolutionized neuroscience in the last decade, the shortcomings of directly stimulating electrodes...

Cite
Mikulovic S, Pupe S, Peixoto HM, et al. On the photovoltaic effect in local field potential recordings. Neurophotonics. 2016;3(1):015002doi: 10.1117/1.NPh.3.1.015002.
Mikulovic, S., Pupe, S., Peixoto, H. M., Do Nascimento, G. C., Kullander, K., Tort, A. B., & Leão, R. N. (2016). On the photovoltaic effect in local field potential recordings. Neurophotonics, 3(1), 015002. https://doi.org/10.1117/1.NPh.3.1.015002
Mikulovic, Sanja, et al. "On the photovoltaic effect in local field potential recordings." Neurophotonics vol. 3,1 (2016): 015002. doi: https://doi.org/10.1117/1.NPh.3.1.015002
Mikulovic S, Pupe S, Peixoto HM, Do Nascimento GC, Kullander K, Tort AB, Leão RN. On the photovoltaic effect in local field potential recordings. Neurophotonics. 2016 Jan;3(1):015002. doi: 10.1117/1.NPh.3.1.015002. Epub 2016 Jan 19. PMID: 26835485; PMCID: PMC4717288.
Copy Download .nbib Format: NLM
Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.

Blood transfusion = Trasfusione del sangue

Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Verna R, Pepe A, Cinque P, Saporito C, Filosa A, Pagano L.
PMID: 27177412
Blood Transfus. 2016 Nov;14(6):538-540. doi: 10.2450/2016.0279-15. Epub 2016 May 03.

No abstract available.

Cite
Ricchi P, Ammirabile M, Costantini S, et al. Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study. Blood Transfus. 2016;14(6):538-540doi: 10.2450/2016.0279-15.
Ricchi, P., Ammirabile, M., Costantini, S., Spasiano, A., Di Matola, T., Verna, R., Pepe, A., Cinque, P., Saporito, C., Filosa, A., & Pagano, L. (2016). Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study. Blood transfusion = Trasfusione del sangue, 14(6), 538-540. https://doi.org/10.2450/2016.0279-15
Ricchi, Paolo, et al. "Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study." Blood transfusion = Trasfusione del sangue vol. 14,6 (2016): 538-540. doi: https://doi.org/10.2450/2016.0279-15
Ricchi P, Ammirabile M, Costantini S, Spasiano A, Di Matola T, Verna R, Pepe A, Cinque P, Saporito C, Filosa A, Pagano L. Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study. Blood Transfus. 2016 Nov;14(6):538-540. doi: 10.2450/2016.0279-15. Epub 2016 May 03. PMID: 27177412; PMCID: PMC5111380.
Copy Download .nbib Format: NLM
Multicultural Family Help Kit.

New South Wales public health bulletin

Pope S, Scanlon K, Raphael B, Heslep J, Cassaniti M, Spiteri J.
PMID: 12105483
N S W Public Health Bull. 2000 Jun;11(6):104-105. doi: 10.1071/nb00048.

No abstract available.

Cite
Pope S, Scanlon K, Raphael B, et al. Multicultural Family Help Kit. N S W Public Health Bull. 2000;11(6):104-105doi: 10.1071/nb00048.
Pope, S., Scanlon, K., Raphael, B., Heslep, J., Cassaniti, M., & Spiteri, J. (2000). Multicultural Family Help Kit. New South Wales public health bulletin, 11(6), 104-105. https://doi.org/10.1071/nb00048
Pope, Suzanne, et al. "Multicultural Family Help Kit." New South Wales public health bulletin vol. 11,6 (2000): 104-105. doi: https://doi.org/10.1071/nb00048
Pope S, Scanlon K, Raphael B, Heslep J, Cassaniti M, Spiteri J. Multicultural Family Help Kit. N S W Public Health Bull. 2000 Jun;11(6):104-105. doi: 10.1071/nb00048. PMID: 12105483.
Copy Download .nbib Format: NLM
Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study.

Reproductive biomedicine online

Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG, Campbell A, Rowe P.
PMID: 12513853
Reprod Biomed Online. 2001;3(3):190-194. doi: 10.1016/s1472-6483(10)62034-2.

Twelve patients (17 cycles) who needed >3000 IU of recombinant FSH (rFSH) on previous follicular stimulation attempts for IVF using rFSH (group A) underwent further attempts (a total of 12 cycles) using rFSH supplemented with rLH from day 7...

Cite
Lisi F, Rinaldi L, Fishel S, et al. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online. 2001;3(3):190-194doi: 10.1016/s1472-6483(10)62034-2.
Lisi, F., Rinaldi, L., Fishel, S., Lisi, R., Pepe, G., Picconeri, M. G., Campbell, A., & Rowe, P. (2001). Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive biomedicine online, 3(3), 190-194. https://doi.org/10.1016/s1472-6483(10)62034-2
Lisi, F, et al. "Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study." Reproductive biomedicine online vol. 3,3 (2001): 190-194. doi: https://doi.org/10.1016/s1472-6483(10)62034-2
Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG, Campbell A, Rowe P. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online. 2001;3(3):190-194. doi: 10.1016/s1472-6483(10)62034-2. PMID: 12513853.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 656 entries